0001179110-11-010023.txt : 20110623 0001179110-11-010023.hdr.sgml : 20110623 20110623104544 ACCESSION NUMBER: 0001179110-11-010023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110622 FILED AS OF DATE: 20110623 DATE AS OF CHANGE: 20110623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elston George CENTRAL INDEX KEY: 0001429932 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 11926988 MAIL ADDRESS: STREET 1: 124 CHATHAM STREET CITY: CHATHAM STATE: NJ ZIP: 07928 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494-2725 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml FORM 4 - X0303 4 2011-06-22 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001429932 Elston George C/O CELLDEX THERAPEUTICS, INC. 119 FOURTH AVENUE NEEDHAM MA 02494 1 0 0 0 Common Stock 2011-06-22 4 A 0 2000 A 2000 D On June 22, 2011, the Company awarded 2,000 shares of Company common stock as an annual equity grant on the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option Plan, subject to time-based forfeiture restrictions. /s/ George Elston 2011-06-23